Definium Therapeutics leadership to appear at Jefferies Healthcare Conference with CEO, CMO, and CFO

Definium Therapeutics leadership to appear at Jefferies Healthcare Conference with CEO, CMO, and CFO
Definium Therapeutics at Jefferies event

Definium Therapeutics has announced that its executive team will participate in a fireside chat at the Jefferies Healthcare Conference this Wednesday, June 3.

The session will feature CEO Robert Barrow, CMO Dan Karlin, and CFO Brandi Roberts and is scheduled for 3:10 PM EDT. Attendees of the event are encouraged to listen in as the leadership discusses the company's latest strategies and updates. Details are being clarified.

Definium Therapeutics recently presented pre-clinical safety results for its psychedelic therapy at the APA Annual Meeting. The company also joined leaders at ASCP in Miami Beach to showcase AI-powered advances for psychiatric drug development. Both events highlighted Definium's ongoing efforts in drug innovation.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.